Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
Clinical trial NCT02489968 · COMPLETED
Trial details
- NCT number
- NCT02489968
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-12
- Primary completion
- 2016-11-18
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.